Marat Fudim, MD MHS Profile picture
Oct 9, 2022 7 tweets 3 min read Read on X
I am a cardiologist, and my work place is above the diaphragm?! Why should I care about the #liver and #NAFLD (non-alcoholic fatty liver disease)?
⚡️Our therapies in many cases reach well beyond the heart
⚡️In order to improve outcomes we have to tackle comorbidities
A🧵
🟦NAFLD (prevalence 25%) isn't only a hepatic disease but also a systemic & CV disease w/o effective pharmacotherapy
🟦We discuss the promising role of SGLT2i in NAFLD, propose mechanisms, & suggest future directions.

sciencedirect.com/science/articl…
The pathogenesis of NAFLD is multifactorial w/ parallel processes that involve insulin resistance, hepatic fat accumulation, increased lipotoxicity, mitochondrial dysfunction, oxidative stress, ER stress, abnormal autophagy, altered gut flora, & apoptosis.
There's an association between NAFLD▶️atherosclerotic CVD + a newly recognized association between NAFLD and incident HF. NAFLD and HF (specifically HFpEF) share several pathophysiological mechanisms (inflammation, endothelial dysfunction, excess epicardial adipose tissue)
Given robust evidence of CV benefits for SGLT2i in diseases that share similar pathophysiological mechanisms as NAFLD, a growing interest in investigating the role of SGLT2i in NAFLD has been undertaken w/ promising signals in (pre)clinical studies. sciencedirect.com/science/articl…
How can SGLT2i potentially be beneficial in NAFLD? We discuss pathways by which SGLT2i can achieve the endpoints of increasing insulin sensitivity; decreasing fat accumulation in the liver, liptotixicty, oxidative stress, & ER stress; improving autophagy; & inhibiting apoptosis.
Dedicated large randomized clinical trails are needed to establish the efficacy of SGLT2i in patients w/ NAFLD

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Marat Fudim, MD MHS

Marat Fudim, MD MHS Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @FudimMarat

Mar 25, 2023
‼️Reduction in cerebral blood flow (CBF) is found in various forms of #Dysautonomia and leads to a broad spectrum of symptoms such as dizziness, fatigue, shortness of breath, all the way out to syncope. Yet, CBF is often not monitored.
pubmed.ncbi.nlm.nih.gov/27525257/ ImageImageImage
sciencedirect.com/science/articl…

We tested the feasibility of a novel continuous monitoring of external carotid blood flow as a proxy for CBF using a novel in-ear device. An in-ear wearable device designed to measure blood flow and more. @HopkinsMedicine @VUMC_heart Tandri, Tripathi ImageImageImage
The device provided near-continuous data on eCBF both during baseline and during periods of syncope. Moreover, changes in the external carotid blood preceded syncope during tilt by several minutes. The in-ear device may improve the sensitivity or maybe even replace tilt testing?!
Read 4 tweets
Nov 4, 2022
#1 Pressures do not equal volumes

▶️ What are the implications for heart failure management❓ Specific examples in patients co-managed with pressure and volume guided analysis are now online:
onlinelibrary.wiley.com/doi/10.1002/eh…

@ShahzebKhanMD @MGKhouri_md @DukeHeartCenter
#2 We previously shown that the most common phenotype of pressure/volume in the HF ambulatory setting are high pressures BUT normal or low blood volume (BLUE BOX)

onlinejcf.com/article/S1071-…
#3 To contextualize and provide concrete examples and impact on clinical management, we report two cases of heart failure (one in HFrEF and one in HFpEF) where pressure-based measurements did not accurately represent the intravascular status and affected clinical management.
Read 9 tweets
Oct 9, 2022
Have you noted that patients with acute #heartfailure (AHF) hyperventilate? @JanBiegus et al. studied hyperventilation (defined by low pCO2 value) AHF and its link with potential triggers and prognosis👏nature.com/articles/s4159… @AlbertoGiannon8 @vbluml @RyanTedfordMD @yulnunezvill
1.Out of 241 AHF patients, 57 (24%) had low pCO2 (pCO2 ≤ 30 mmHg). Low pCO2 group had significantly lower HCO3- (22.3 ± 3.4 vs 24.7 ± 2.9 mmol/L, p < 0.0001) and significantly higher lactate level (2.53 ± 1.6 vs 2.14 ± 0.97 mmol/L, p = 0.03).
2.No differences between groups were observed in respect to following potential triggers: hypoxia (sO2, p = 0.57), infection (CRP, p = 0.47), dyspnea severity and pulmonary congestion
Read 5 tweets
Jul 30, 2022
Great thread on the link of Ehlers Danlos Syndrome (EDS) and Dysautonomia/POTS.

To extend on the observations some additional points 🧵:

#1 EDS is commonly associated with venous abnormalities such as nutcracker physiology of abdominal vessels or May Thurner syndrome.
#2 The issue with venous distension in the abdomen and pelvis is that it creates venous pooling/obstruction to blood return. Its mostly in the abdomen and not legs!
#3 The consequence are abdominal symptoms often reported by EDS and dysautonomia/POTS patients such as Chronic abdominal pain, Bladder fullness, Flank pain etc...

The Clinical Problem of Pelvic Venous Disorders
interventional.theclinics.com/article/S2211-…
Read 8 tweets
Jul 15, 2022
📢COVID-19 and Incident Heart Failure in @NatureComms

🟥 COVID-19 hospitalization is associated w/ a 45% higher hazard of incident HF
🟥 More pronounced association among pts who are younger, White, or w/ established CVD

nature.com/articles/s4146…
🌟-team @HusamSalah @CaugheyPhD Image
🚨As of July 4, 2022, there were about 529 million pts who recovered from COVID-19. The association between COVID-19 recovery and incident HF has not been studied in a large scale, nationally representative sample.
🚨We examined post-recovery outcomes of 587,330 pts hospitalized in the US using data from the N3C study w/ a median F/U of 367 days. W/O adjustments, post-recovery COVID-19 was associated with a 69% higher hazard of post-discharge incident HF and 45% higher hazard W/ adjustment.
Read 6 tweets
Feb 12, 2022
🔥🚨Pressures Do Not Equal Volumes🚨
#1
We present ➡️ Discordance of Pressure and Volume: Potential Implications for Pressure-Guided
Remote Monitoring in Heart Failure
➡️We explored pressure-volume relationship
in ambulatory HF pts. managed with CardioMEMS
onlinejcf.com/article/S1071-…
#2
⚡️Pulmonary arterial diastolic (PAD)/wedge pressure are surrogate markers for (intra-vascular) blood volume (BV) and are often used to guide volume adjusting therapy (aka diuretics)
⚡️We found no relationship between PAD pressure and intra-vascular BV
#3
⚡️Majority of patients had high pressures but low-normal volume (blue box)
⚡️Minority had high pressure/high volume (yellow)
⚡️We found a moderate relationship between PAD and stressed BV (fluid shifts) ▶️ Fluid shifts rather than fluid retention were driving force of high PAD
Read 8 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Don't want to be a Premium member but still want to support us?

Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal

Or Donate anonymously using crypto!

Ethereum

0xfe58350B80634f60Fa6Dc149a72b4DFbc17D341E copy

Bitcoin

3ATGMxNzCUFzxpMCHL5sWSt4DVtS8UqXpi copy

Thank you for your support!

Follow Us!

:(